✦ LIBER ✦

Etoposide, doxorubicin and cisplatin (EAP) treatment in advanced gastric carcinoma: a multicentre study of the Italian Trials in Medical Oncology (I.T.M.O.) Group

✍ Scribed by Bajetta, E.; Di Bartolomeo, M.; de Braud, F.; Bozzetti, F.; Bochicchio, A.M.; Comella, P.; Fagnani, D.; Farina, G.; Ferroni, C.; Franchi, R.; Gebbia, V.; Ianniello, G.; Iirillo, A.; Pinotti, G.; Schieppati, G.; Ucci, G.; Visini, M.; Zaniboni, A.; Buzzoni, R.; Casartelli, C.; Nelli, P.

Book ID: 122086293
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 679 KB
Volume: 30
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(94)90527-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The combination of cisplatin, doxorubici

The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma: A phase II randomized trial of the Italian oncology group for clinical research

✍ Vincenzo De Lisi; Giorgio Cocconi; Francesco Angelini; Francesco Cavicchi; Franc 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB 👁 2 views

## BACKGROUND. In a randomized Phase I1 study, the authors evaluated the activity and toxicity of the new cisplatin, doxorubicin, and mitomycin C (PAM) comhination, that includes cisplatin (P) instead of 5-fluorouracil as in the 5-fluorouracil, doxorubicin, and mitomycin C (FAM) Combination, in pat

Phase II Study of Mitomycin, Doxorubicin

Phase II Study of Mitomycin, Doxorubicin, and Cisplatin in the Treatment of Advanced Uterine Leiomyosarcoma: A Gynecologic Oncology Group Study

✍ John H. Edmonson; John A. Blessing; Jonathan A. Cosin; David Scott Miller; David 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 42 KB

6628 POSTER A Combination of RAD001 and

6628 POSTER A Combination of RAD001 and Octreotide LAR as First-line Treatment of Well Differentiated Neuroendocrine Tumours – an I.T.M.O. (Italian Trials in Medical Oncology) Group Study

✍ Bajetta, E.; Catena, L.; Biondani, P.; Fazio, N.; Giuffrida, D.; Ricci, S.; Aiet 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

6626 POSTER Efficacy and Safety of RAD00

6626 POSTER Efficacy and Safety of RAD001 as Second Line Therapy in Biliary Tract Cancer (BTC) Patients (pts) – a Phase II I.T.M.O. (Italian Trials in Medical Oncology) Group Study

✍ Buzzoni, R.; Pusceddu, S.; Biondani, P.; Cantore, M.; Aitini, E.; Bertolini, A.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Clinical efficacy of octreotide in the t

Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors: A study by the Italian Trials in Medical Oncology group

✍ Maria Di Bartolomeo; Emilio Bajetta; Roberto Buzzoni; Luigi Mariani; Carlo Carna 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 668 KB

## Background: The unsatisfactory control of neuroendocrine tumor growth with chemotherapy and/or interferon (ifn-2a) stimulated us to investigate the role of the somatostatin analogue octreotide (sms 201.995), which is reported to be highly effective in controlling carcinoid syndrome symptoms. oct

Phase II trials of cisplatin and piperaz

Phase II trials of cisplatin and piperazinedione in advanced or recurrent squamous cell carcinoma of the vulva: A gynecologic oncology group study

✍ J.Tate Thigpen; John A. Blessing; Howard D. Homesley; George C. Lewis Jr 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 376 KB